{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:50:29Z","timestamp":1767084629126,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,4]],"date-time":"2018-03-04T00:00:00Z","timestamp":1520121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.02.114","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:26:51Z","timestamp":1521386811000},"page":"2126-2132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children"],"prefix":"10.1016","volume":"36","author":[{"given":"Soedjatmiko","family":"Soedjatmiko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernie Endyarni","family":"Medise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartono","family":"Gunardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rini","family":"Sekartini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hindra Irawan","family":"Satari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri Rezeki","family":"Hadinegoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novilia Sjafri","family":"Bachtiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rini Mulia","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.114_b0005","unstructured":"UNICEF. The state of the world\u2019s children 1996, 50th Anniversary Edition. UNICEF. http:\/\/www.UNICEF.org\/sowc96\/about.htm [Cited 23.06.18]."},{"key":"10.1016\/j.vaccine.2018.02.114_b0010","unstructured":"Public Health Agency of Canada. Canada Communicable Disease Report; Statement on Influenza vaccination for the 2014\u20132015 Season Mar 8, 2016 http:\/\/www.phac-aspc.gc.ca\/naci-ccni\/assets\/pdf\/flu-2015-grippe-eng.pdf [Cited 07.02.17]."},{"key":"10.1016\/j.vaccine.2018.02.114_b0015","unstructured":"Fukuda K, Levandowski RA, Bridges CB, Cox N. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, editors, With assistance of Offit PA, Vaccines. Philadelphia: Saunders; 2004. p. 339\u2013700."},{"key":"10.1016\/j.vaccine.2018.02.114_b0020","unstructured":"FDA\/CBER. Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza vaccines; Guidance for Industry, 09\/10\/2007. http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm091985.pdf [Cited 20.07.15]."},{"key":"10.1016\/j.vaccine.2018.02.114_b0025","unstructured":"WHO. Recommended composition of influenza virus vaccines for use in the 2015\u20132016 northern hemisphere influenza season. Australia; 2015. p. 1\u20136."},{"key":"10.1016\/j.vaccine.2018.02.114_b0030","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1542\/peds.2006-1694","article-title":"Accuracy and interpretation of rapid influenza test in children","volume":"119","author":"Grijalva","year":"2007","journal-title":"Pediatrics"},{"issue":"14","key":"10.1016\/j.vaccine.2018.02.114_b0035","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2015.12160","article-title":"Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination","volume":"314","author":"Grijalva","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.02.114_b0040","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children; a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.114_b0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.14238\/sp16.2.2014.136-42","article-title":"Infeksi Influenza A dan B pada Anak dengan Influenza-like Illness (ILI) atau Pneumonia di Jakarta","volume":"16","author":"Indawati","year":"2014","journal-title":"Sari Pediatri"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.114_b0050","first-page":"7","article-title":"Influenza cases from surveillance acute respiratory infection in Indonesia, 2011","volume":"5","author":"Pangesti","year":"2014","journal-title":"Health Sci Indonesia"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.114_b0055","doi-asserted-by":"crossref","first-page":"20162527","DOI":"10.1542\/peds.2016-2527","article-title":"Recommendations for prevention and control of influenza in children, 2016\u20132017","volume":"138","author":"AAP Committee on Infectious Diseases","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.114_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.21776\/ub.jkb.2012.027.02.9","article-title":"Respon Imun terhadap Vaksin Influenza pada Remaja","volume":"27","author":"Dhamayanti","year":"2012","journal-title":"Jurnal Kedokteran Brawijaya"},{"key":"10.1016\/j.vaccine.2018.02.114_b0065","unstructured":"Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan Republik Indonesia. Total Number of Influenza from Puskesmas (ILI) of Flu Positive by Week in Indonesia: week 1-53, 2014. www.litbang.depkes.go.id [Cited 20.07.15]."},{"key":"10.1016\/j.vaccine.2018.02.114_b0070","unstructured":"Rusmil K, Fadlyana E, Dhamayanti M, Gunadi R, Bachtiar NS. Protectivity and safety of influenza HA vaccine (PT Bio Farma) in adolescents and adults. Poster Presentation Indonesian Influenza Foundation Symposium; 2013."},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.114_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14238\/pi51.1.2011.22-8","article-title":"Immunogenicity and safety of a trivalent inactivated influenza vaccine","volume":"51","author":"Fadlyana","year":"2011","journal-title":"Paediatr. Indonesiana"},{"key":"10.1016\/j.vaccine.2018.02.114_b0080","doi-asserted-by":"crossref","first-page":"A22","DOI":"10.1016\/j.vaccine.2011.04.123","article-title":"Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia","volume":"29S","author":"Suhardono","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.114_b0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jpids\/piu061","article-title":"Safety and immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) compared with Half-Dose TIV administered to children 6 through 35 months of age","volume":"4","author":"Halasa","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.114_b0090","first-page":"284","article-title":"Immune response against inactivated influenza vaccine in children under four years old","volume":"81","author":"Irie","year":"2007","journal-title":"J Japanese Assoc Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.114_b0095","unstructured":"Bachtiar NS, Sukriyani Y, Lestari, Sari RM. Validation of Hemagglutination Inhibition Assay for influenza antibody titer. Poster presentation at Indonesian Influenza Foundation Symposium; 2013."},{"key":"10.1016\/j.vaccine.2018.02.114_b0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","article-title":"Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season","volume":"33","author":"Belongia","year":"2015","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2018.02.114_b0105","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1017\/S0950268815000771","article-title":"The East Jakarta Project: surveillance for highly pathogenic avian influenza A (H5N1) and seasonal influenza viruses in patients seeking care for respiratory disease, Jakarta, Indonesia, October 2011\u2013September 2012","volume":"143","author":"Storms","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.114_b0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.14238\/sp12.4.2010.278-82","article-title":"Surveilans influenza pada Pasien Rawat Jalan","volume":"12","author":"Purniti","year":"2010","journal-title":"Sari Pediatri"},{"key":"10.1016\/j.vaccine.2018.02.114_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiu186","article-title":"Association between antibody titers and protection against influenza virus infection within household","volume":"210","author":"Tsang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.114_b0120","doi-asserted-by":"crossref","unstructured":"Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2016\u201317 influenza season. MMWR 2016; 65(5).","DOI":"10.15585\/mmwr.rr6505a1"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.114_b0125","doi-asserted-by":"crossref","first-page":"e0167281","DOI":"10.1371\/journal.pone.0167281","article-title":"Effect of influenza vaccination of children on infection rate in hutterite communities: follow-up study of a randomized trial","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.02.114_b0130","doi-asserted-by":"crossref","unstructured":"Ranuh IGN, Suyitno H, Hadinegoro SR, Kartasasmita CB, Ismoedijanto, Soedjatmiko. Pedoman Imunisasi di Indonesia. Satgas Imunisasi IDAI; 2017.","DOI":"10.14238\/sp8.1.2006.84-92"},{"key":"10.1016\/j.vaccine.2018.02.114_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/irv.12399","article-title":"Interim estimates of the effectiveness of influenza vaccination against influenza-associated hospitalization in children in Hong Kong, 2015\u201316","volume":"11","author":"Cowling","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.114_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/irv.12302","article-title":"Influenza vaccination coverage and effectiveness in young children in Thailand, 2011\u20132013","volume":"9","author":"Kittikraisak","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"10.1016\/j.vaccine.2018.02.114_b0145","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/infdis\/jiw380","article-title":"Seasonal influenza vaccination of children induces humoral and cell-mediated immunity beyond the current season: cross-reactivity with past and future strains","volume":"214","author":"Reber","year":"2016","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2018.02.114_b0150","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/infdis\/jiu650","article-title":"Influenza vaccine effectiveness in households with children during the 2012\u20132013 season: assessments of prior vaccination and serologic susceptibility","volume":"211","author":"Ohmit","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.114_b0155","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1542\/peds.2006-0201","article-title":"Immunization with Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers","volume":"118","author":"Englund","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.02.114_b0160","doi-asserted-by":"crossref","unstructured":"Kang EK, Eun BW, Kim NH, Lim JS, Lee Ja, Kim DH. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study. BMC Inf Dis 2016; 16: 438. 10.1186\/s12879-016-1769-7.","DOI":"10.1186\/s12879-016-1769-7"},{"issue":"6","key":"10.1016\/j.vaccine.2018.02.114_b0165","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/INF.0000000000000254","article-title":"Safety and immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in children 6 months through 8 years of age","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.114_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.12659\/MSM.889876","article-title":"The neurologist dilemma: a comprehensive clinical review of Bell\u2019s palsy, with emphasis on current management trends","volume":"20","author":"Zandian","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2018.02.114_b0175","unstructured":"WHO. Information Sheet: Observed Rate of Vaccine Reactions Influenza Vaccine. http:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/Influenza_Vaccine_rates_information_sheet.pdf; 2012. p. 1\u20138 [Cited 23.06.15]."},{"key":"10.1016\/j.vaccine.2018.02.114_b0180","first-page":"175","article-title":"Immunization and Bell\u2019s palsy in Children: A Case-Centered Analysis","volume":"1","author":"Rowhani-Rahbar","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.114_b0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kwp345","article-title":"Near real-time surveillance for influenza vaccine safety: proof-of-concept in the vaccine safety data link project","volume":"171","author":"Greene","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.02.114_b0190","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.02.114_b0195","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden","volume":"343","author":"Bardage","year":"2011","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:37Z","timestamp":1759400797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18303244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":39,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18303244"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.114","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}